FDA Import Refusal SCS-2717878-6/10002/1 — NOVO NORDISK
The FDA refused shipment SCS-2717878-6/10002/1 from NOVO NORDISK (Canada) on Apr 24, 2026. The refused product falls under Drugs and Biologics — INSULIN DEGLUDEC. Cited charge: 118 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Apr 24, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 58HDY07 INSULIN DEGLUDEC
- Charges
- 118